Increased levels of uric acid and calcium in the body

Son güncelleme: Ağustos 17, 2026

Increased levels of uric acid and calcium in the body can be linked to several pathological conditions. Below is a detailed explanation of the potential causes for the elevation of each substance:

---

1. Uric Acid: Causes of Increased Levels (Hyperuricemia)

Uric acid is a byproduct of purine metabolism, and its excessive accumulation can occur due to increased production, decreased excretion, veya her ikisi.

A. Metabolik Bozukluklar:

• Gut: Uric acid crystals deposit in joints, causing inflammation and pain.
• Metabolic Syndrome: Associated with obesity, insülin direnci, hipertansiyon, and hyperlipidemia, often causing hyperuricemia.
• Diyabet Mellitus: Insulin resistance can impair uric acid excretion through the kidneys.

B. Kidney Disorders:

• Kronik Böbrek Hastalığı (KBH): Reduced excretion of uric acid due to impaired renal function.
• Acute Kidney Injury (AKİ): Sudden kidney dysfunction can lead to uric acid accumulation.

C. Increased Purine Breakdown:

• Cancer and Chemotherapy: Rapid cell turnover and breakdown during treatment release purines, increasing uric acid.
• Hemolytic Anemias: Accelerated breakdown of red blood cells releases purines.

D. Dietary and Lifestyle Factors:

• High-Purine Diet: Consumption of foods like red meat, deniz ürünleri, and alcohol can raise uric acid levels.
• Dehidrasyon: Concentrated urine can impair uric acid clearance.

e. Genetic or Enzymatic Defects:

• Lesch-Nyhan Syndrome: A rare genetic disorder of purine metabolism.
• HGPRT Deficiency: Impaired purine salvage pathway leads to excess uric acid.

---

2. Calcium: Causes of Increased Levels (Hypercalcemia)

Calcium levels in the blood are tightly regulated by hormones like parathyroid hormone (PTH) and vitamin D. Hypercalcemia can result from increased calcium release, absorption, or retention.

A. Endocrine Disorders:

• Primary Hyperparathyroidism: Overactive parathyroid glands increase calcium release from bones and reabsorption in the kidneys.
• Secondary Hyperparathyroidism: Often due to chronic kidney disease or vitamin D deficiency, leading to altered calcium metabolism.

B. Malignancies:

• Bone Metastases: Cancer spreading to bones (E.G., göğüs, akciğer) can increase calcium release.
• Multipil myeloma: Cancer of plasma cells affecting bone density and calcium levels.
• Paraneoplastic Syndrome: Tumors may secrete PTH-related peptides that raise calcium levels.

C. Vitamin D-Related Issues:

• Vitamin D Intoxication: Excessive supplementation increases calcium absorption from the gut.
• Granulomatous Diseases (E.G., Sarcoidosis, Tüberküloz): Granulomas can produce active vitamin D, elevating calcium levels.

D. İlaçlar:

• Thiazide Diuretics: Increase calcium reabsorption in the kidneys.
• Lithium: Can affect parathyroid gland function, raising calcium levels.

e. Immobilization:

• Prolonged bed rest or immobility causes calcium to leach from bones into the bloodstream.

F. Genetic Disorders:

• Familial Hypocalciuric Hypercalcemia: A benign genetic condition leading to mild hypercalcemia.

G. Renal Disorders:

• Milk-Alkali Syndrome: Excessive intake of calcium and absorbable alkali leads to hypercalcemia and renal dysfunction.

---

Combined Elevation of Uric Acid and Calcium:

The simultaneous increase of uric acid and calcium may occur in conditions such as:

• Kronik Böbrek Hastalığı: Impaired filtration leads to reduced excretion of both substances.
• Tumor Lysis Syndrome: Rapid cell destruction (E.G., after chemotherapy) releases uric acid and calcium into the bloodstream.
• Metabolic Syndrome: Often involves disturbances in both calcium and uric acid metabolism.

---

Diagnostic Approach:

If both uric acid and calcium are elevated, the following evaluations may be necessary:

1. Blood Tests: Measure PTH, D vitamini, kidney function, and markers of bone turnover.
2. Urine Tests: Assess calcium and uric acid excretion.
3. Imaging Studies: Bone scans, ultrasonlar, or CT scans to evaluate parathyroid glands or potential malignancies.
4. Dietary and Medication Review: Evaluate dietary habits and medications that may influence these levels.

Proper management involves treating the underlying condition, which may require specialist input such as a nephrologist, endocrinologist, or oncologist.